chloroquine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Kopin, IJ; Lipsky, RH; Marini, AM; Schwartz, JP | 1 |
Alexander, GM; D'Amato, RJ; Kitt, CA; Price, DL; Schwartzman, RJ; Snyder, SH | 1 |
Benham, DF; D'Amato, RJ; Snyder, SH | 1 |
Bawankule, DU; Binwal, M; Chaudhary, MJ; Kartik, S; Kumar, M; Nath, R; Pal, R | 1 |
4 other study(ies) available for chloroquine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Accumulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in cultured cerebellar astrocytes.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Ammonium Chloride; Animals; Astrocytes; Cells, Cultured; Cerebellum; Chloroquine; Lysosomes | 1992 |
Neuromelanin: a role in MPTP-induced neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Cations, Divalent; Chloroquine; Dopamine; Haplorhini; Homovanillic Acid; Humans; Melanins; Pyridines; Pyridinium Compounds; Substantia Nigra; Tyrosine 3-Monooxygenase | 1987 |
Characterization of the binding of N-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, to neuromelanin.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Binding, Competitive; Cattle; Chloroquine; Humans; Hydrogen-Ion Concentration; Melanins; Pyridines; Pyridinium Compounds; Ranidae; Substantia Nigra | 1987 |
Neuroprotective role of chloroquine via modulation of autophagy and neuroinflammation in MPTP-induced Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autophagy; Chloroquine; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Inflammation; Mice; Mice, Inbred C57BL; Neuroinflammatory Diseases; Neuroprotective Agents; Parkinson Disease; Rats; Tumor Necrosis Factor-alpha | 2023 |